References
- Dickert NW, Llanos A, Samady H. Re-visiting consent for clinical research on acute myocardial infarction and other emergent conditions. Progress in cardiovascular diseases. 2012;55:251–7.
- Agard A, Herlitz J, Hermeren G. Obtaining informed consent from patients in the early phase of acute myocardial infarction: Physicians’ experiences and attitudes. Heart. 2004;90:208–10.
- Wood S. HEAT-PPCI: Heparin bests bivalirudin in STEMI, amid heated debate. medscape. 1 April 2014. [Internet] Available at: http://www.medscape.com/viewarticle/822927 (accessed 19 December 2014).
- Gammelgaard A, Mortensen O, Rossel P in collaboration with the DANAMI-2 Investigators. Patients’ perceptions of informed consent in acute myocardial infarction research: A questionnaire based survey of the consent process in the DANAMI-2 trial. Heart. 2004;90:1124–8.
- Gammelgaard A, Rossel P, Mortensen O in collaboration with the DANAMI-2 Investigators. Patients’ perceptions of informed consent in acute myocardial infarction research: a Danish study. Soc Sci Med. 2004;58:2313–24.
- Ågard A, Hermerén G, Herlitz J. Patients’ experiences of intervention trials on the treatment of myocardial infarction: Is it time to adjust the informed consent procedure to the patients' capactiy? Heart 2001;86:632–7.
- Yuval R, Halon D, Merdler A, Khader N, Karkabi B, Uziel K, et al. Patient comprehension and reaction to participating in a double-blind randomized clinical trial (ISIS-4) in acute myocardial infarction. Arch Intern Med. 2000;160:1142–6.
- Cassell C. Template analysis. In: Thorpe R, Holt R, editors. The Sage dictionary of qualitative management research. London, UK: Sage Publications Ltd; 2008. pp. 221–23. (accessed today, 19 December 2014: http://srmo.sagepub.com/view/the-sage-dictionary-of-qualitative-management-research/n105.xml)
- Gammelgaard A. Informed consent in acute myocardial infarction research. J Med Philos. 2004;29:417–34.
- Selker HP, Beshansky JR, Griffith JL, D’Agostino RB, Massaro JM, Udelson JE, et al. Study design for the immediate myocardial metabolic enhancement during initial assessment and treatment in emergency care (IMMEDIATE) trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J. 2012;163:315–22.
- U.S. Department of Health and Human Services. Title 45 (Code of Federal Regulations), Part 46 Protection of Human Subjects. 2009.
- U.S. Food and Drug Administration. Title 21 (Code of Federal Regulations), Part 50.24 Protection of Human Subjects.2004.